Valuation: Isodiol International Inc

Market Cap 3.91M 2.73M 2.49M 2.29M 2.08M 253M 4.11M 27.9M 11.09M 138M 10.25M 10.03M 434M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.38M 5.81M 5.35M 4.87M 591M 9.6M 65.14M 25.89M 323M 23.93M 23.42M 1.01B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Manager TitleAgeSince
Chief Executive Officer - 23/05/2017
Corporate Officer/Principal - 29/08/2018
Director TitleAgeSince
Director/Board Member - 23/05/2017
Director/Board Member - 29/08/2018
Director/Board Member - 20/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.58%+881.08% - - 128
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average -0.06%-4.76%+25.01%+75.64% 452B
Weighted average by Cap. +0.30%-5.19%+26.02%+87.88%

Financials

2018 2019
Net sales 19.14M 13.36M 12.17M 11.21M 10.2M 1.24B 20.11M 136M 54.25M 676M 50.14M 49.08M 2.12B 22.25M 15.53M 14.15M 13.04M 11.86M 1.44B 23.38M 159M 63.06M 786M 58.28M 57.06M 2.47B
Net income -36.02M -25.15M -22.91M -21.11M -19.2M -2.33B -37.86M -257M -102M -1.27B -94.37M -92.38M -3.99B -126M -87.92M -80.07M -73.78M -67.12M -8.14B -132M -898M -357M -4.45B -330M -323M -13.96B
Net Debt -15.55M -10.86M -9.89M -9.11M -8.29M -1.01B -16.34M -111M -44.08M -549M -40.74M -39.88M -1.72B 5.22M 3.65M 3.32M 3.06M 2.78M 338M 5.49M 37.24M 14.8M 184M 13.68M 13.39M 579M
Logo Isodiol International Inc
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-